Diffusion-weighted MR imaging of liver on 3.0-Tesla system: Effect of intravenous administration of gadoxetic acid disodium

European Radiology

Volumn 20, Issue 5, 2010, Pages 1052-1060

  Choi, Ji Soo ^a   Kim, Myeong Jin ^a,b   Choi, Jin Young ^a   Park, Mi Suk ^a   Lim, Joon Seok ^a   Kim, Ki Whang ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

3.0 T; Diffusion weighted imaging; Gadoxetic acid disodium; Hepatic lesion; Magnetic resonance imaging

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER METASTASIS; MALE; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; CYSTS; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 77952093634     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1651-8     Document Type: Article

References (22)

1. D Le Bihan R Turner P Douek N Patronas 1992 Diffusion MR imaging: clinical applications AJR Am J Roentgenol 159 3 591 599 1503032
2. DM Koh DJ Collins 2007 Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 1622 1635 10.2214/AJR.06.1403 17515386 (Pubitemid 46866868)
3. P Lang MF Wendland M Saeed, et al. 1998 Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging Radiology 206 227 235 1:STN:280:DyaK1c%2FosFOgtw%3D%3D 9423677
4. Y Guo YQ Cai ZL Cai, et al. 2002 Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging J Magn Reson Imaging 16 172 178 10.1002/jmri.10140 12203765 (Pubitemid 34810055)
5. Y Okada K Ohtomo S Kiryu Y Sasaki 1998 Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient J Comput Assist Tomogr 22 364 371 10.1097/00004728-199805000-00005 1:STN:280:DyaK1c3mvFahsg%3D%3D 9606375 (Pubitemid 28396727)
6. DM Koh E Scurr DJ Collins, et al. 2006 Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging Eur Radiol 16 1898 1905 10.1007/s00330-006-0201-x 1:STN:280: DC%2BD28vnt1OlsQ%3D%3D 16691378 (Pubitemid 44193174)
7. T Ichikawa H Haradome J Hachiya T Nitatori T Araki 1998 Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions AJR Am J Roentgenol 170 397 402 1:STN:280:DyaK1c7hvVSluw%3D%3D 9456953 (Pubitemid 28083846)
8. K Butts SJ Riederer RL Ehman JP Felmlee RC Grimm 1993 Echo-planar imaging of the liver with a standard MR imaging system Radiology 189 259 264 1:STN:280:DyaK3szotlSltA%3D%3D 8396785
9. K Nasu Y Kuroki S Nawano, et al. 2006 Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging Radiology 239 122 130 10.1148/radiol.2383041384 16493012
10. T Moteki T Sekine 2004 Echo planar MR imaging of the liver: comparison of images with and without motion probing gradients J Magn Reson Imaging 19 82 90 10.1002/jmri.10430 14696224 (Pubitemid 38055733)
11. M Bruegel K Holzapfel J Gaa, et al. 2008 Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique Eur Radiol 18 477 485 10.1007/s00330-007-0785-9 17960390 (Pubitemid 351248179)
12. CJ Zech KA Herrmann MF Reiser SO Schoenberg 2007 MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA Magn Reson Med Sci 6 43 52 10.2463/mrms.6.43 17510541
13. P Reimer G Schneider W Schima 2004 Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications Eur Radiol 14 559 578 10.1007/s00330-004-2236-1 14986050 (Pubitemid 38444568)
14. B Hamm T Staks A Muhler, et al. 1995 Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 785 792 1:STN:280:DyaK2M3ntlGrsg%3D%3D 7754011
15. FY Chiu JC Jao CY Chen, et al. 2005 Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions J Comput Assist Tomogr 29 176 180 10.1097/01.rct.0000157472.98277.5c 15772533 (Pubitemid 40411300)
16. P Reimer EJ Rummeny K Shamsi, et al. 1996 Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 177 183 1:STN:280:DyaK283gtFyqug%3D%3D 8633143
17. M Rohrer H Bauer J Mintorovitch M Requardt HJ Weinmann 2005 Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths Invest Radiol 40 715 724 10.1097/01.rli.0000184756.66360.d3 16230904 (Pubitemid 41546838)
18. SC Yu DT Yeung NM So 2004 Imaging features of hepatocellular carcinoma Clin Radiol 59 145 156 10.1016/S0009-9260(03)00316-7 1:STN:280: DC%2BD2c%2Fks1Sltg%3D%3D 14746783 (Pubitemid 38159840)
19. Hussain SM, Zondervan PE, IJzermans JNM, Schalm SW, de Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023-1036; discussion 1037-1029
20. SM Hussain RC Semelka DG Mitchell 2002 MR imaging of hepatocellular carcinoma Magn Reson Imaging Clin N Am 10 31 52 10.1016/S1064-9689(03)00048-5 11998574 (Pubitemid 34205580)
21. KM Elsayes VR Narra Y Yin G Mukundan M Lammle JJ Brown 2005 Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging Radiographics 25 1299 1320 10.1148/rg.255045180 16160113 (Pubitemid 41695347)
22. M Bollow M Taupitz B Hamm T Staks KJ Wolf HJ Weinmann 1997 Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation Eur Radiol 7 126 132 10.1007/s003300050125 1:STN:280:DyaK2s7ltlGgsQ%3D%3D 9000414